Bringing the fundamentals into focus…
Bringing the fundamentals into focus…
KRYS · against 178 other Healthcare companies of similar size
Ranked #98 of 179 · scores higher than 44% of peers
Bars: peers in each 10-point band of the valuation score27 peers with a valuation score of 50–59, including KRYS · Click a bar to see the companies
Its metrics sit close to the Healthcare norm.
| Metric | KRYS | Peer median | Better than | Position among peers | Weight |
|---|---|---|---|---|---|
| Earnings yieldHigher is better · 178 reported | 2.6% | 2.5% | 52% | 30% | |
| EBITDA yieldHigher is better · 178 reported | 2.4% | 4.6% | 32% | 50% | |
| Free cash flow yieldHigher is better · 105 reported | 2.9% | 1.8% | 61% | 20% | |
| Book yieldHigher is better · 178 reported | 15.1% | 19.6% | 39% | Context only |
| Rank | Company | Market cap | Valuation | Overall |
|---|---|---|---|---|
| 1 | 52.2B HKD (≈$6.7B) | 99 | 56 | |
| 1 | 37.3B HKD (≈$4.8B) | 99 | 90 | |
| 3 | 89.5B HKD (≈$11.5B) | 98 | 67 | |
| 4 | 10.4B USD | 96 | 64 | |
| 5 | 80.2B CNY (≈$11.2B) | 95 | 76 | |
| 94 | 379.9B INR (≈$4.6B) | 51 | 55 | |
| 94 | 11.9B USD | 51 | 53 | |
| 98 | 558.5B INR (≈$6.7B) | 50 | 47 | |
| 98 | 521.3B INR (≈$6.3B) | 50 | 69 | |
| 98 | 9.0B USD | 50 | 78 | |
| 98 | 6.3B USD | 50 | 78 | |
| 102 | 10.8B USD | 49 | 35 | |
| 102 | 15.8B EUR (≈$17.4B) | 49 | 47 | |
| 104 | 34.2B CNY (≈$4.8B) | 48 | 59 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score